Future Directions in Research and Treatment
Looking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.
Debating the Possibility of Epstein-Barr Virus–Targeted Treatments for MS
Expert panelists review the viability of new treatments in development for multiple sclerosis.
Understanding Varying Latency Periods for Epstein-Barr Virus and Onset of MS
Alberto Ascherio, MD, DrPH, addresses the range of latency periods for Epstein-Barr virus and the impact on onset multiple sclerosis.
Translating New Advances to the Clinic
Alberto Ascherio, MD, DrPH; Anne Cross, MD; and Michael Racke, MD, discuss implications for patient communication and other advances from bench to bedside.
Therapeutic Implications Regarding the Role of Epstein-Barr Virus in MS
The expert panelists comment on intervention efforts underway to address multiple sclerosis prevention and treatment.
Examining Immune Response to Epstein-Barr Virus
A panel of experts probe the variations in immune response to Epstein-Barr virus in patients with multiple sclerosis.
Exploring Contributing Risk Factors to MS
Alberto Ascherio, MD, DrPH, highlights key risk factors leading to increased prevalence of multiple sclerosis.
Priming the Immune System for MS
Anne Cross, MD, and Michael Racke, MD, discuss how the immune system is primed in multiple sclerosis.
Viruses and Autoimmune Disease
Avindra Nath, MD, explains the importance of understanding virology when treating autoimmune diseases.
Elucidating the Association Between Epstein-Barr Virus and Multiple Sclerosis
Alberto Ascherio, MD, DrPH, recaps key findings and learning from a recently published study that he coauthored demonstrating a causal relationship between MS and Epstein-Barr virus.
Multiple Sclerosis Centers Offer Value
The benefits of a multidisciplinary hub for disease management can mitigate the costs.
2 Clarke Drive Cranbury, NJ 08512